Proto Labs officer plans $446K share sale
The shares are attributed to restricted stock units that vested from February 13, 2023, through May 20, 2025.
Rhea-AI Filing Summary
Proto Labs, Inc. officer Daniel Schumacher reported an intended sale of 5,000 common shares, with an aggregate market value of $445,650.00, through Morgan Stanley Smith Barney LLC Executive Financial Services. The shares were acquired through the vesting of restricted stock units from February 13, 2023, through May 20, 2025. His reported prior three-month sales, each identified as a 10b5-1 sale, were 4,900 shares on September 17, 2026, and 100 shares on September 16, 2026.
Positive
- None.
Negative
- None.
Key Figures
Common shares intended for sale: 5,000 shares
Aggregate market value: $445,650.00
Shares outstanding: 23,921,897 shares
+2 more
5 metrics
Common shares intended for sale
5,000 shares
Reported intended sale
Aggregate market value
$445,650.00
For the 5,000 common shares intended for sale
Shares outstanding
23,921,897 shares
Count listed in the sale information
Prior 10b5-1 sale
4,900 shares; $417,535.37
September 17, 2026
Prior 10b5-1 sale
100 shares; $8,500.00
September 16, 2026
Key Terms
restricted stock units, 10b5-1, aggregate market value
3 terms
restricted stock units financial
"acquired upon the vesting of restricted stock units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
10b5-1 regulatory
"10b5-1 Sales for DANIEL SCHUMACHER"
A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.
aggregate market value financial
"Aggregate market value of securities to be sold"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.